(Q50187490)

26 February 2018

title

Expression of cyclooxygenase-2 and transforming growth factor-beta1 in HCV-induced chronic liver disease and hepatocellular carcinoma. (English)

1 reference

26 February 2018

main subject

chronic liver disease

0 references

author name string

Azza E I El-Bassiouny

1

1 reference

26 February 2018

Mona M K Zoheiry

2

1 reference

26 February 2018

Mona M F Nosseir

3

1 reference

26 February 2018

Eman G El-Ahwany

4

1 reference

26 February 2018

Raafat A Ibrahim

5

1 reference

26 February 2018

Nora E I El-Bassiouni

6

1 reference

26 February 2018

publication date

28 August 2007

1 reference

26 February 2018

MedGenMed : Medscape general medicine

published in

1 reference

26 February 2018

volume

9

1 reference

26 February 2018

issue

3

1 reference

26 February 2018

page(s)

45

1 reference

26 February 2018

Transforming growth factor-beta and response to anticancer therapies in human liver and gastric tumors in vitro and in vivo

cites work

1 reference

12 December 2020

Cyclo-oxygenase 2 expression impairs serum-withdrawal-induced apoptosis in liver cells.

1 reference

12 December 2020

Enhanced expression of cyclooxygenase-2 in high grade human transitional cell bladder carcinomas

1 reference

12 December 2020

Expression of cyclooxygenase-2 (COX-2) in hepatocellular carcinoma and growth inhibition of hepatoma cell lines by a COX-2 inhibitor, NS-398.

1 reference

12 December 2020

TGF-beta signaling in tumor suppression and cancer progression

1 reference

12 December 2020

Predictive value of expression of transforming growth factor-beta(1) and its receptors in transitional cell carcinoma of the urinary bladder

1 reference

12 December 2020

Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein

1 reference

12 December 2020

Roles of TGF-beta in hepatic fibrosis

1 reference

12 December 2020

COX-2 inhibitors in cancer treatment and prevention, a recent development

1 reference

12 December 2020

Rationale and feasibility of chemoprovention of hepatocellular carcinoma by cyclooxygenase-2 inhibitors

1 reference

12 December 2020

Cyclooxygenase-2 mRNA is up-regulated in cirrhotic or chronic hepatitis liver adjacent to hepatocellular carcinoma

1 reference

12 December 2020

Proapoptotic and antiproliferative potential of selective cyclooxygenase-2 inhibitors in human liver tumor cells

1 reference

12 December 2020

Significance of cyclooxygenase-2 expression in human primary hepatocellular carcinoma

1 reference

12 December 2020

The hepatitis B virus X protein promotes tumor cell invasion by inducing membrane-type matrix metalloproteinase-1 and cyclooxygenase-2 expression

1 reference

12 December 2020

Combination of a selective cyclooxygenase-2 inhibitor with epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 and protein kinase A antisense causes cooperative antitumor and antiangiogenic effect.

1 reference

12 December 2020

The two faces of transforming growth factor beta in carcinogenesis

1 reference

12 December 2020

The role and regulation of COX-2 during viral infection

1 reference

12 December 2020

Expression of HBx and COX-2 in chronic hepatitis B, cirrhosis and hepatocellular carcinoma: implication of HBx in upregulation of COX-2.

1 reference

12 December 2020

Increased intrahepatic cyclooxygenase 2, matrix metalloproteinase 2, and matrix metalloproteinase 9 expression is associated with progressive liver disease in chronic hepatitis C virus infection: role of viral core and NS5A proteins

1 reference

12 December 2020

Human cyclooxygenase-2 cDNA

1 reference

12 December 2020

The morphologic transition in hepatocellular carcinoma. A comparison of the individual histologic features disclosed by ultrasound-guided fine-needle biopsy with those of autopsy

1 reference

12 December 2020

[Primary liver cancer. Its epidemiological, clinical and biochemical characteristics]

1 reference

12 December 2020

Early advanced hepatocellular carcinoma: evaluation of CT and MR appearance with pathologic correlation

1 reference

12 December 2020

Transforming growth factor beta and cell cycle regulation

1 reference

12 December 2020

Eicosanoids and the gastrointestinal tract

1 reference

12 December 2020

Sulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenocarcinoma cells

1 reference

12 December 2020

Histological grading and staging of chronic hepatitis

1 reference

12 December 2020

Acarboxy prothrombin (PIVKA II) as a tumour marker for hepatocellular carcinoma and other liver diseases

1 reference

12 December 2020

Quantitation of alpha-fetoprotein and albumin messenger RNA in human hepatocellular carcinoma

1 reference

12 December 2020

[Carcino-fetal antigens].

1 reference

12 December 2020

Induction of cyclo-oxygenase-2 by cytokines in human cultured airway smooth muscle cells: novel inflammatory role of this cell type

1 reference

12 December 2020

Cyclooxygenase in biology and disease

1 reference

12 December 2020

Increased expression of transforming growth factor-beta1 and thrombospondin-1 in congenital hepatic fibrosis: possible role of the hepatic stellate cell

1 reference

12 December 2020

Expression of insulin-like growth factor I by activated hepatic stellate cells reduces fibrogenesis and enhances regeneration after liver injury.

1 reference

12 December 2020

Hepatitis C Virus Stimulates the Expression of Cyclooxygenase-2 via Oxidative Stress: Role of Prostaglandin E2 in RNA Replication

1 reference

12 December 2020

The tumor suppressor Smad4 is required for transforming growth factor beta-induced epithelial to mesenchymal transition and bone metastasis of breast cancer cells

1 reference

12 December 2020

Modulation of the transforming growth factor-beta signal transduction pathway by hepatitis C virus nonstructural 5A protein

1 reference

12 December 2020

Molecular mechanisms of inactivation of TGF-beta receptors during carcinogenesis

1 reference

12 December 2020

Identifiers

1 reference

26 February 2018